Candel Therapeutics, Inc. (CADL) Insider Trading -- Recent Executive & Director Transactions

10 insiders reported 20 Form 4 transactions for Candel Therapeutics, Inc. (CADL) over the past 18 months (most recent 2026-09-11). Recent activity: Tak Paul Peter (Chief Executive Officer) Buy 125,000 shares, Tak Paul Peter (Chief Executive Officer) Sell 220,866 shares, Tak Paul Peter (Chief Executive Officer) Sell 59,379 shares, Tyagarajan Seshu (Chief Technology Officer) Sell 7,000 shares, Barone Francesca (Chief Scientific Officer) Sell 23,447 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-09-11Tak Paul PeterChief Executive OfficerBuy125,000$193,750
2026-09-11Tak Paul PeterChief Executive OfficerSell220,866$2.5M
2026-09-11Tak Paul PeterChief Executive OfficerSell59,379$620,891
2026-08-19Tyagarajan SeshuChief Technology OfficerSell7,000$84,000
2026-07-01Barone FrancescaChief Scientific OfficerSell23,447$235,769
2026-07-01Tyagarajan SeshuChief Technology OfficerSell7,000$70,151
2026-02-26Manning Paul BDirectorBuy550,458$3.0M
2025-07-30Nichols William GarrettChief Medical OfficerBuy937$1,209
2025-07-30Nichols William GarrettChief Medical OfficerSell937$6,540
2025-07-02Nichols William GarrettChief Medical OfficerBuy781$1,007
2025-07-02Nichols William GarrettChief Medical OfficerSell781$3,936
2025-06-26Manning Paul BDirectorBuy1.1M$5.0M
2025-06-26Barone FrancescaChief Scientific OfficerBuy4,282$19,997
2025-06-26Tak Paul PeterChief Executive OfficerBuy42,826$199,997
2025-06-26Martell ChristopherDirectorBuy111,349$520,000
2025-06-26Nabel Gary J.DirectorBuy5,353$24,999
2025-06-26Schoch CharlesChief Financial OfficerBuy5,353$24,999
2025-06-26PAPA JOSEPH CDirectorBuy64,239$299,996
2025-06-26Loggia NicolettaDirectorBuy2,141$9,998
2025-06-26Tyagarajan SeshuChief Technology OfficerBuy5,353$24,999

Source: SEC Form 4 filings · as of 2026-09-11